Kodak promotes advances at AHRA
Productivity enhancements, high-speed film, and a CAD system for mammography headlined the Kodak booth the first week of August at the annual meeting of the American Healthcare Radiology Administrators in Boston. The Kodak DirectView Capture Link System
Productivity enhancements, high-speed film, and a CAD system for mammography headlined the Kodak booth the first week of August at the annual meeting of the American Healthcare Radiology Administrators in Boston. The Kodak DirectView Capture Link System helps technologists identify and process cassettes and gives them the ability to review images at any linked computed radiography or digital radiography system. The work-in-progress CAD system, targeted for commercial release later this year, analyzes film mammograms. Clinical data submitted to the FDA show that 39.4% of missed breast cancers could have been detected 14.8 months earlier using this system.
A new high-speed general-purpose medical imaging film shown as a work-in-progress promises to reduce patient radiation dosage by up to 50% yet deliver high image quality.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
Could an Emerging PET Tracer be a Game Changer for Detecting Hepatocellular Carcinoma?
June 23rd 2025In addition to over 90 percent sensitivity in detecting hepatocellular carcinoma (HCC), the glypican-3 (GPC3) targeted PET tracer 68Ga-aGPC3-scFv appeared to be advantageous in identifying HCC tumors smaller than one centimeter, according to pilot study findings presented at the SNMMI conference.
SNMMI: What a New Meta-Analysis Reveals About Radiotracers for PET/CT Detection of PCa
June 22nd 2025While (68Ga)Ga-PSMA-11 offers a pooled sensitivity rate of 92 percent for prostate cancer, (18F)-based radiotracers may offer enhanced lesion detection as well as improved imaging flexibility, according to a meta-analysis presented at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.
